Bed Bath & Beyond (NASDAQ:BBBY) had its price objective dropped by investment analysts at Jefferies Group to $25.00 in a research report issued to clients and investors on Friday. The firm presently has an “underperform” rating on the retailer’s stock. Jefferies Group’s price objective would suggest a potential upside of 16.28% from the stock’s previous close. Jefferies Group also issued estimates for Bed Bath & Beyond’s Q4 2018 earnings at $1.43 EPS, Q1 2019 earnings at $0.42 EPS, Q2 2019 earnings at $0.67 EPS, Q3 2019 earnings at $0.36 EPS, Q4 2019 earnings at $1.45 EPS and FY2019 earnings at $2.87 EPS.
A number of other brokerages also recently commented on BBBY. Zacks Investment Research upgraded shares of Bed Bath & Beyond from a “hold” rating to a “buy” rating and set a $33.00 price objective for the company in a research report on Thursday, September 14th. KeyCorp reiterated an “underweight” rating and set a $21.00 price target (down from $27.00) on shares of Bed Bath & Beyond in a research report on Wednesday, September 20th. Moffett Nathanson initiated coverage on shares of Bed Bath & Beyond in a research report on Monday, December 4th. They set a “neutral” rating for the company. UBS reiterated a “neutral” rating and set a $30.00 price target (down from $33.00) on shares of Bed Bath & Beyond in a research report on Thursday, September 14th. Finally, Morgan Stanley set a $22.00 price target on shares of Bed Bath & Beyond and gave the company a “sell” rating in a research report on Thursday. Eight analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have assigned a buy rating to the company. The company has an average rating of “Hold” and an average price target of $26.24.
Shares of Bed Bath & Beyond (NASDAQ BBBY) opened at $21.50 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.77 and a quick ratio of 0.33. The company has a market cap of $3,593.95, a PE ratio of 6.81 and a beta of 1.10. Bed Bath & Beyond has a 12-month low of $19.07 and a 12-month high of $44.29.
Hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. lifted its holdings in Bed Bath & Beyond by 2,768.5% in the 1st quarter. BlackRock Inc. now owns 12,120,048 shares of the retailer’s stock worth $478,258,000 after buying an additional 11,697,533 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Bed Bath & Beyond by 19.8% in the 4th quarter. Vanguard Group Inc. now owns 13,701,292 shares of the retailer’s stock worth $661,087,000 after buying an additional 2,261,926 shares in the last quarter. Renaissance Technologies LLC bought a new stake in shares of Bed Bath & Beyond in the 2nd quarter worth about $68,548,000. Norges Bank bought a new stake in shares of Bed Bath & Beyond in the 4th quarter worth about $87,296,000. Finally, Bank of New York Mellon Corp increased its position in shares of Bed Bath & Beyond by 41.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 6,859,643 shares of the retailer’s stock worth $295,720,000 after purchasing an additional 2,020,716 shares during the last quarter. 91.72% of the stock is owned by institutional investors.
Bed Bath & Beyond Company Profile
Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).
